Exelixis (EXEL) Receivables - Other (2010 - 2025)
Exelixis (EXEL) recorded quarterly Receivables - Other of $1.6 million in Q4 2025, up 2.88% quarter-over-quarter from $1.5 million in Q3 2025, and up 471.64% on a YoY basis from $275000.0 in Q4 2024.
Exelixis (EXEL) Receivables - Other (2010 - 2025) Analysis & Trends
Exelixis' Receivables - Other history runs 12 years deep, the most recent figure standing at $1.6 million for Q4 2025.
- In Q4 2025, Receivables - Other rose 471.64% year-over-year to $1.6 million; the TTM figure through Oct 2025 stood at $1.6 million (up 471.64% YoY), while the FY2025 annual figure was $369000.0, down 72.07% from the prior year.
- Receivables - Other was $1.6 million for Q4 2025 at Exelixis, up from $1.5 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $10.7 million in Q3 2021 to a low of $275000.0 in Q3 2024.
- Historically, Receivables - Other has averaged $1.7 million across 5 years, with a median of $1.3 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Receivables - Other plunged 96.32% in 2022, then soared 471.64% in 2025.
- A 5-year view of Receivables - Other shows it stood at $1.7 million in 2021, then dropped by 0.36% to $1.7 million in 2022, then dropped by 20.37% to $1.3 million in 2023, then tumbled by 79.18% to $275000.0 in 2024, then jumped by 471.64% to $1.6 million in 2025.
- The last three Receivables - Other figures came in at $1.6 million (Q4 2025), $1.5 million (Q3 2025), and $326000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 3, 2025 | 1.57 Mn |
| Oct 3, 2025 | 1.57 Mn |
| Jul 4, 2025 | 1.53 Mn |
| Jul 4, 2025 | 1.53 Mn |
| Apr 4, 2025 | 326,000.00 |
| Apr 4, 2025 | 326,000.00 |
| Jan 3, 2025 | 369,000.00 |
| Jan 3, 2025 | 369,000.00 |
| Sep 27, 2024 | 275,000.00 |
| Sep 27, 2024 | 275,000.00 |
| Jun 28, 2024 | 1.47 Mn |
| Jun 28, 2024 | 1.47 Mn |
| Mar 29, 2024 | 1.34 Mn |
| Mar 29, 2024 | 1.34 Mn |
| Dec 29, 2023 | 1.32 Mn |
| Dec 29, 2023 | 1.32 Mn |
| Sep 29, 2023 | 635,000.00 |
| Sep 29, 2023 | 635,000.00 |
| Jun 30, 2023 | 1.26 Mn |
| Jun 30, 2023 | 1.26 Mn |